790 related articles for article (PubMed ID: 15050313)
1. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
2. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
4. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
[TBL] [Abstract][Full Text] [Related]
5. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
6. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
[TBL] [Abstract][Full Text] [Related]
7. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
8. Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma.
Kong F; Jirtle RL; Huang DH; Clough RW; Anscher MS
Cancer; 1999 Nov; 86(9):1712-9. PubMed ID: 10547543
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
[TBL] [Abstract][Full Text] [Related]
11. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
13. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy.
Fay M; Tan A; Fisher R; Mac Manus M; Wirth A; Ball D
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1355-63. PubMed ID: 15817337
[TBL] [Abstract][Full Text] [Related]
15. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
[TBL] [Abstract][Full Text] [Related]
16. In regard to De Jaeger et al.: significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer (INT J RADIAT ONCOL BIOL PHYS 2004;58:1378-1387).
Anscher MS; Kong FM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1276-7. PubMed ID: 15752910
[No Abstract] [Full Text] [Related]
17. Predictors of radiation pneumonitis after radiotherapy in lung cancer.
Jeremic B; Hennig M; Zimmermann FB
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):302. PubMed ID: 15629626
[No Abstract] [Full Text] [Related]
18. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer.
Liu Y; Yu H; Zhang C; Cheng Y; Hu L; Meng X; Zhao Y
Eur J Cancer; 2008 Nov; 44(16):2425-32. PubMed ID: 18789680
[TBL] [Abstract][Full Text] [Related]
19. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
20. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.
Chen HW; Chang YC; Lai YL; Chen YJ; Huang MJ; Leu YS; Fu YK; Wang LW; Hwang JJ
Jpn J Clin Oncol; 2005 Aug; 35(8):427-32. PubMed ID: 16006572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]